Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey

The Gaucher Outcome Survey (GOS) is an international disease-specific registry established in 2010 for patients with a confirmed diagnosis of Gaucher disease (GD), regardless of GD type or treatment status. Historically, there has been a limited understanding of type 3 GD (GD3) and its natural histo...

Full description

Bibliographic Details
Published in:	Molecular Genetics and Metabolism Reports
Main Authors:	Ida Vanessa D. Schwartz, Özlem Göker-Alpan, Priya S. Kishnani, Ari Zimran, Lydie Renault, Zoya Panahloo, Patrick Deegan
Format:	Article
Language:	English
Published:	Elsevier 2018-03-01
Subjects:	Type 3 Gaucher disease Gaucher Outcome Survey Velaglucerase alfa Enzyme replacement therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426917301416

Similar Items

Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience
by: Ozlem Goker-Alpan, et al.
Published: (2025-10-01)

EFFECTIVENESS AND SAFETY OF VELAGLUCERASE ALFA IN TREATMENT OF GAUCHER DISEASE TYPE 1 (ACCORDING TO INTERNATIONAL STUDIES)
by: O. S. Gundobina, et al.
Published: (2014-11-01)

Demographic, Clinical and Genetic Characteristics of Child Gaucher Disease Patients in Russia: Pediatric Register Data
by: G. B. Movsisyan, et al.
Published: (2016-11-01)

An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan
by: Hiroyuki Ida, et al.
Published: (2022-11-01)

The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease
by: Margarita M. Ivanova, et al.
Published: (2024-04-01)

Safety analysis of self-administered enzyme replacement therapy using data from the Fabry Outcome and Gaucher Outcome Surveys
by: Shoshana Revel-Vilk, et al.
Published: (2025-03-01)

Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease
by: Gupta P, et al.
Published: (2017-06-01)

Gaucher Disease and Gaucher Cells
by: Sevgi Gözdaşoğlu
Published: (2015-05-01)

Taliglucerase alfa in the longterm treatment of children and adolescents with type 1 Gaucher disease: the Albanian experience
by: Paskal Cullufi, et al.
Published: (2024-02-01)

Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey
by: Ari Zimran, et al.
Published: (2025-01-01)

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease
by: Marcio Andrade-Campos, et al.
Published: (2017-05-01)

Enfermedad de Gaucher en Colombia
by: Gerzain Rodríguez, et al.
Published: (1972-01-01)

Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease
by: Ari Zimran, et al.
Published: (2018-02-01)

Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease
by: Renuka P. Limgala, et al.
Published: (2020-03-01)

Simultaneous Bilateral Femoral Osteonecrosis in Gaucher Disease
by: Daniel Cohen, et al.
Published: (2023-05-01)

Gaucher Disease for Hematologists
by: Gül Nihal Özdemir, et al.
Published: (2022-05-01)

Gaucher disease: achievements and prospects
by: Rodion V. Ponomarev, et al.
Published: (2021-07-01)

Gaucher's disease - a review of the most important information about the disease in Paediatrics
by: Jakub Jarmołowicz, et al.
Published: (2025-07-01)

Gaucher Cells or Pseudo-Gaucher Cells: That's the Question
by: Deniz Gören Şahin, et al.
Published: (2014-12-01)

Changing clinical manifestations of Gaucher disease in Taiwan
by: Wen-Li Lu, et al.
Published: (2023-09-01)

Age-related inflammatory biomarkers in early-onset osteoporosis in females with Gaucher disease
by: Margarita M. Ivanova, et al.
Published: (2025-07-01)

Gaucher disease type 2 (case report)
by: D. R. Shagieva, et al.
Published: (2020-09-01)

Experiencia cubana en la terapia de reemplazo enzimático en la Enfermedad de Gaucher
by: Kalia Lavaut Sánchez, et al.

Quantification of glucosylceramide in plasma of Gaucher disease patients
by: Maria Viviane Gomes Muller, et al.
Published: (2010-12-01)

Spanish consensus on managing pregnancy in women with Gaucher disease
by: Enrique J. Calderón, et al.
Published: (2025-03-01)

Obstacles to Early Diagnosis of Gaucher Disease
by: Nishimura S, et al.
Published: (2025-01-01)

Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma
by: Gianluca Bossù, et al.
Published: (2023-05-01)

EVALUATION OF ENZYME REPLACEMENT THERAPY EFFECTIVENESS IN CHILDREN WITH GAUCHER’S DISEASE ACCORDING TO THE INTERNATIONAL STUDIES
by: O. S. Gundobina, et al.
Published: (2014-05-01)

Early-Onset Colorectal Cancer in a Young Woman with Type 1 Gaucher Disease
by: Nevenka Ridova, et al.
Published: (2022-06-01)

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?
by: Veroniki Komninaka, et al.
Published: (2023-11-01)

Coexistence or a related condition: an infant with retinoblastoma and Gaucher disease
by: Burcu Berberoğlu-Ateş, et al.
Published: (2019-06-01)

Gaucher Disease: A First Reported Adult Case in Indonesia
by: Ardhi Rahman Ahani, et al.
Published: (2024-04-01)

TUBERCULOSIS SACROILITIS WITH COXITIS IN THE PATIENT SUFFERING FROM GAUCHER DISEASE
by: V. A. Khomenko, et al.
Published: (2018-09-01)

Gaucher Disease: A First Reported Adult Case in Indonesia
by: Ardhi Rahman Ahani, et al.
Published: (2024-01-01)

Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
by: Margarita M. Ivanova, et al.
Published: (2022-11-01)

Esplenomegalia gigante por enfermedad de Gaucher
by: Raysy Sardiñas Ponce, et al.
Published: (2021-12-01)

Macitentan in the treatment of pulmonary hypertension in Gaucher's disease
by: Gokay Taylan, et al.
Published: (2020-01-01)

Event-based real-life outcomes of patients with non-neuronopathic Gaucher disease receiving ert
by: Ayşe Akyüz, et al.
Published: (2025-06-01)

Gaucher Disease Involving Virchow’s Lymph Node: a Case Report
by: Zinovkin Dmitry A., et al.
Published: (2018-12-01)

Thrombocytopenia and GBA gene mutation in a patient with adult type 1 Gaucher disease
by: Lagen Wan, et al.
Published: (2017-11-01)